Dupixent Data Could Scratch A Regulatory Itch

 
• By Elizabeth Cairns
  
magnifying glass and stacks of coins
Dupixent progresses in chronic urticaria and bullous pemphigoid (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapeutic Category